Salicylic Acid

Salicylic Acid

SCHEMBL546852

O=C([O-])c1ccccc1O.O=C([O-])c1ccccc1O.[Mn+2]

nearest known ligand 0.91

Full drug profile on Sugi Atlas →

Known targets — ChEMBL curated mechanism

ACHE

The experimentally established mechanism targets of Salicylic Acid. The predicted profile below is derived independently by chemical similarity — agreement is a validation signal, a miss is honest.

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ KDM4E B2RXH2 7/20 0.91
▸ HPGD P15428 6/20 0.91
▸ ALDH1A1 P00352 3/20 0.91
▸ SMN1; SMN2 Q16637 3/20 0.58
▸ CA1 P00915 2/20 0.58
▸ CA9 Q16790 2/20 0.58
▸ CA12 O43570 1/20 0.58
▸ CA2 P00918 1/20 0.58
▸ HMGB1 P09429 1/20 0.58
▸ CA4 P22748 1/20 0.58
▸ CA6 P23280 1/20 0.58
▸ CA7 P43166 1/20 0.58
▸ NAPRT Q6XQN6 1/20 0.58
▸ CA14 Q9ULX7 1/20 0.58
▸ HSD17B10 Q99714 3/20 0.56
▸ MAPT P10636 3/20 0.56
▸ TSHR P16473 2/20 0.56
▸ GAA P10253 2/20 0.52
▸ MPO P05164 1/20 0.52
▸ HIF1A Q16665 1/20 0.52

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Salicylic Acid SCHEMBL6249450 0.97 KDM4E (0.95) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL458273 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL6934680 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL11599872 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL9981 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL3132735 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL1026592 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL11514957 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL12477385 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1
Salicylic Acid SCHEMBL7205746 0.95 KDM4E (0.91) KDM4EHPGDALDH1A1SMN1; SMN2CA1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 406 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-119505316-A Manufacturing method of anti-tearing temperature-resistant CPP film for electronic screen protection 南通苍峰新材料科技有限公司 2025-02-25 — — CN claimed
EP-3802752-B1 METHOD FOR PREVENTING OR REDUCING LOW SPEED PRE-IGNITION IN DIRECT INJECTED SPARK-IGNITED ENGINES WITH MANGANESE-CONTAINING LUBRICANT CHEVRON USA INC (US) 2023-07-19 — — EP claimed
CN-112368361-B Method of preventing or reducing low speed pre-ignition in a direct injection spark ignition engine with a manganese-containing lubricant 雪佛龙美国公司 2022-11-01 — — CN claimed
EP-3802752-A1 METHOD FOR PREVENTING OR REDUCING LOW SPEED PRE-IGNITION IN DIRECT INJECTED SPARK-IGNITED ENGINES WITH MANGANESE-CONTAINING LUBRICANT Chevron U.S.A. Inc. (US) 2021-04-14 — — EP claimed
CN-112368361-A Method of preventing or reducing low speed pre-ignition in a direct injection spark ignition engine with a manganese-containing lubricant 雪佛龙美国公司 2021-02-12 — — CN claimed
CN-108417795-B Preparation method of transition metal/transition metal carbodiimide composite material 陕西科技大学 2020-11-27 — — CN claimed
WO-2018231782-A2 METAL COMPLEXES AS PHARMACEUTICALS FOR TREATMENT AND PREVENTION OF CANCER AND INFLAMMATORY DISEASES UNIVERSITY OF SOUTHERN CALIFORNIA (US) 2018-12-20 — — WO claimed
US-20180353539-A1 METAL COMPLEXES AS PHARMACEUTICALS FOR TREATMENT AND PREVENTION OF CANCER AND INFLAMMATORY DISEASES UNIV SOUTHERN CALIFORNIA (US) 2018-12-13 — — US claimed
CN-108417795-A A kind of preparation method of transition metal/transition metal carbodiimide composite material 陕西科技大学 2018-08-17 — — CN claimed
US-9717939-B2 Fire extinguishing composition containing transition metal compound XI'AN WESTPEACE FIRE TECHNOLOGY CO., LTD (CN) 2017-08-01 — — US claimed
EP-1431372-A2 Use of manganese compounds to inhibit both low- and high-temperature corrosion in utility and industrial furnace systems ETHYL CORPORATION (US) 2004-06-23 — — EP claimed
CN-1506614-A Transfer of manganese from lubricant source to fuel combustion system 乙基公司 2004-06-23 — — CN claimed
US-20040110104-A1 Delivering manganese from a lubricant source into a fuel combustion system AFTON CHEMICAL INTANGIBLES LLC 2004-06-10 — — US claimed
US-20040105894-A1 Trace Metals synergized copper nucleotides and copper glycosides for anti-aging and antiviral compositions GUPTA SHYAM K (US) 2004-06-03 — — US claimed
US-6136292-A Determination of non-functioning areas of the g.i. tract using MRI of manganese composition NYCOMED IMAGING AS (NO) 2000-10-24 — — US claimed
US-6120756-A REDUCE SEBUM Markowitz, Philip I. (US) 2000-09-19 — — US claimed
EP-0941127-A2 METHOD NYCOMED IMAGING AS (NO) 1999-09-15 — — EP claimed
WO-1998011922-A2 METHOD NYCOMED IMAGING AS (NO) 1998-03-26 — — WO claimed
US-4535048-A Toner for development of electrostatic charges CANON KABUSHIKI KAISHA (JP) 1985-08-13 — — US claimed
US-4057534-A Method for preventing scale formation in a continuous ester-interchange reaction for production of polyesters TEIJIN LIMITED (JA) 1977-11-08 — — US claimed
Send feedback